[Federal Register Volume 82, Number 167 (Wednesday, August 30, 2017)]
[Notices]
[Pages 41267-41268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18407]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-0004]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to <a href="/cdn-cgi/l/email-protection#741b1916341710175a131b02"><span class="__cf_email__" data-cfemail="7c13111e3c1f181f521b130a">[email protected]</span></a>. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    National Disease Surveillance Program II. Disease Summaries (OMB 
Control Number 0920-0004, Expires 10/31/2017)--Revision--National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three-year approval for the proposed revision of the 
``National Disease Surveillance Program II. Disease Summaries'' 
information collection project.
    As with the previous approval, these data are essential for 
measuring trends in diseases, evaluating the effectiveness of current 
preventive strategies, and determining the need to modify current 
preventive measures.

[[Page 41268]]

    Diseases included in this surveillance program are Influenza Virus, 
Caliciviruses, Respiratory and Enteric Viruses, Foodborne Outbreaks, 
Waterborne Outbreaks and Enteroviruses.
    Proposed revisions include form consolidation, minor revised 
language and rewording to improve clarity and readability of the data 
collection forms and the discontinuation of multiple previously 
approved influenza collection instruments, and the National Respiratory 
& Enteric Virus Surveillance System (NREVSS) Laboratory Assessment (CDC 
55.83). CDC also requests the use of a new form, Suspect Respiratory 
Virus Patient Form, to assist health departments and clinical sites 
when they submit specimens to the CDC lab for viral pathogen 
identification. The data will enable rapid detection and 
characterization of outbreaks of known pathogens, as well as potential 
newly emerging viral pathogens.
    The frequency of response for each form will depend on the disease 
and surveillance need. This represents a 7,116 burden hour reduction 
since last approval. This reduction in burden hours is attributed 
primarily to the discontinuation of previously approved forms and 
formatting changes to existing forms. The total time burden estimate 
for all collection instruments in this revision request is 24,805.
    There are no costs to the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondent                   Form name             Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist.......................  NORS Foodborne Disease                 54              37           20/60
                                        Transmission_Person to
                                        Person Disease
                                        Transmission_Animal
                                        Contact_Environmental
                                        Contamination_Unknown
                                        Transmission Mode_52.13.
Epidemiologist.......................  WHO COLLABORATING CENTER               53              52           10/60
                                        FOR INFLUENZA Influenza
                                        Virus Surveillance.
Epidemiologist.......................  U.S. WHO Collaborating                113               1           10/60
                                        Laboratories Influenza
                                        Testing Methods
                                        Assessment.
Epidemiologist.......................  US Outpatient Influenza-            1,800              52           10/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Weekly_CDC
                                        55.20.
Epidemiologist.......................  US Outpatient Influenza-             1800               1            5/60
                                        like Illness
                                        Surveillance Network
                                        (ILINet) Workfolder
                                        55.20E.
Epidemiologist.......................  Influenza-Associated                   57               2           30/60
                                        Pediatric Mortality Case
                                        Report Form.
Epidemiologist.......................  Human Infection with                   57               2           30/60
                                        Novel Influenza A Virus
                                        Case Report Form.
Epidemiologist.......................  Human Infection with                   57               1           90/60
                                        Novel Influenza A Virus
                                        Severe Outcomes.
Epidemiologist.......................  Novel Influenza A Virus                57               1           15/60
                                        Case Screening Form.
Epidemiologist.......................  Antiviral Resistant                    57               3           30/60
                                        Influenza Infection Case
                                        Report Form.
Epidemiologist.......................  National Respiratory &                550              52           15/60
                                        Enteric Virus
                                        Surveillance System
                                        (NREVSS) (55.83A, B, D)
                                        (electronic).
Epidemiologist.......................  National Enterovirus                   20              12           15/60
                                        Surveillance Report:
                                        (CDC 55.9) (electronic).
Epidemiologist.......................  National Adenovirus Type               13               4           15/60
                                        Reporting System (NATRS).
Epidemiologist.......................  Middle East Respiratory                57               3           25/60
                                        Syndrome (MERS) Patient
                                        Under Investigation
                                        (PUI) Short Form.
Epidemiologist.......................  Viral Gastroenteritis                  20               5            5/60
                                        Outbreak Submission Form.
Epidemiologist.......................  NORS Waterborne Disease                59               1           20/60
                                        Transmission Form_52.12.
Epidemiologist.......................  Influenza Virus                        57              52            5/60
                                        (Electronic, Year
                                        Round), PHLIP_HL7
                                        messaging Data Elements.
Epidemiologist.......................  Influenza virus                         3              52            5/60
                                        (electronic, year round)
                                        (PHIN-MS).
Epidemiologist.......................  Suspect Respiratory Virus              10               5           30/60
                                        Patient Form.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-18407 Filed 8-29-17; 8:45 am]
 BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>